Immunocapture and microplate-based activity measurement of mammalian pyruvate dehydrogenase complex

Analytical Biochemistry

Volumn 314, Issue 1, 2003, Pages 121-127

  Lib, Margarita ^a   Rodriguez Mari, Adriana ^a   Marusich, Michael F ^a   Capaldi, Roderick A ^a  

^a UNIVERSITY OF OREGON   (United States)

Author keywords

Activity assay; Immunocapture; Phosphorylation; Pyruvate dehydrogenase

Indexed keywords

CELL CULTURE; MAMMALS; MONOCLONAL ANTIBODIES; NEURODEGENERATIVE DISEASES; PHOSPHORYLATION;

ACTIVITY ASSAYS; ACTIVITY MEASUREMENTS; ALZHEIMER'S DISEASE; FLUORESCENCE ASSAY; IMMUNOCAPTURE; MITOCHONDRIAL PROTEIN; PYRUVATE DEHYDROGENASE COMPLEX; PYRUVATES;

ENZYME ACTIVITY;

ENZYME INHIBITOR; MITOCHONDRIAL PROTEIN; MONOCLONAL ANTIBODY; PYRUVATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME DEFICIENCY; ENZYME INHIBITION; ENZYME METABOLISM; FIBROBLAST; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; MAMMAL; MITOCHONDRION; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PYRUVATE DEHYDROGENASE DEFICIENCY; SCREENING; SPECTROPHOTOMETRY;

MAMMALIA;

EID: 0037333309     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-2697(02)00645-0     Document Type: Article

References (45)

1. Cross J.H., Connelly A., Gadian D.G., Kendall B.E., Brown G.K., Brown R.M., Leonard J.V. Clinical diversity of pyruvate dehydrogenase deficiency. Pediatr. Neurol. 10:1994;276-283.
2. Patel M.S., Harris R.A. Mammalian alpha-keto acid dehydrogenase complexes: Gene regulation and genetic defects. FASEB J. 9:1995;1164-1172.
3. Wu P., Sato J., Zhao Y., Jaskiewicz J., Popov K.M., Harris R.A. Starvation and diabetes increase the amount of pyruvate dehydrogenase kinase isoenzyme 4 in rat heart. Biochem. J. 329(Pt 1):1998;197-201.
4. Bigl M., Bruckner M.K., Arendt T., Bigl V., Eschrich K. Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease. J. Neural. Transm. 106:1999;499-511.
5. Vary T.C., Hazen S. Sepsis alters pyruvate dehydrogenase kinase activity in skeletal muscle. Mol. Cell. Biochem. 198:1999;113-118.
6. Heininger K. A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events, Rev. Neurosci. 11, Spec No, (2000) 213-328.
7. Roche T.E., Baker J.C., Yan X., Hiromasa Y., Gong X., Peng T., Dong J., Turkan A., Kasten S.A. Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms. Prog. Nucleic Acid Res. Mol. Biol. 70:2001;33-75.
8. Reed L.J., Lawson J.E., Niu X.D., Yazdi M.A., Fussey S.P. Biochemical and molecular genetic aspects of eukaryotic pyruvate dehydrogenase multienzyme complexes. J. Nutr. Sci. Vitaminol. (Tokyo) Spec. 1992;46-51.
9. Jilka J.M., Rahmatullah M., Kazemi M., Roche T.E. Properties of a newly characterized protein of the bovine kidney pyruvate dehydrogenase complex. J. Biol. Chem. 261:1986;1858-1867.
10. Patel M.S., Roche T.E. Molecular biology and biochemistry of pyruvate dehydrogenase complexes. FASEB J. 4:1990;3224-3233.
11. Gudi R., Bowker-Kinley M.M., Kedishvili N.Y., Zhao Y., Popov K.M. Diversity of the pyruvate dehydrogenase kinase gene family in humans. J. Biol. Chem. 270:1995;28989-28994.
12. Bowker-Kinley M.M., Davis W.I., Wu P., Harris R.A., Popov K.M. Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex. Biochem. J. 329(Pt 1):1998;191-196.
13. Bowker-Kinley M., Popov K.M. Evidence that pyruvate dehydrogenase kinase belongs to the ATPase/kinase superfamily. Biochem. J. 344(Pt 1):1999;47-53.
14. Wu P., Inskeep K., Bowker-Kinley M.M., Popov K.M., Harris R.A. Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes. Diabetes. 48:1999;1593-1599.
15. Baker J.C., Yan X., Peng T., Kasten S., Roche T.E. Marked differences between two isoforms of human pyruvate dehydrogenase kinase. J. Biol. Chem. 275:2000;15773-15781.
16. Steussy C.N., Popov K.M., Bowker-Kinley M.M., Sloan R.B. Jr., Harris R.A., Hamilton J.A. Structure of pyruvate dehydrogenase kinase. Novel folding pattern for a serine protein kinase. J. Biol. Chem. 276:2001;37443-37450.
17. Sugden P.H., Hutson N.J., Kerbey A.L., Randle P.J. Phosphorylation of additional sites on pyruvate dehydrogenase inhibits its re-activation by pyruvate dehydrogenase phosphate phosphatase. Biochem. J. 169:1978;433-435.
18. Sugden P.H., Randle P.J. Regulation of pig heart pyruvate dehydrogenase by phosphorylation. Studies on the subunit and phosphorylation stoichiometries. Biochem. J. 173:1978;659-668.
19. Sugden P.H., Simister N.E. Role of multisite phosphorylation in the regulation of ox kidney pyruvate dehydrogenase complex. FEBS Lett. 111:1980;299-302.
20. Korotchkina L.G., Khailova L.S., Severin S.E. The effect of phosphorylation on pyruvate dehydrogenase. FEBS Lett. 364:1995;185-188.
21. Chow C.W., Thorburn D.R. Morphological correlates of mitochondrial dysfunction in children. Hum. Reprod. 15(Suppl. 2):2000;68-78.
22. Nissenkorn A., Michelson M., Ben-Zeev B., Lerman-Sagie T. Inborn errors of metabolism: a cause of abnormal brain development. Neurology. 56:2001;1265-1272.
23. De Vivo D.C. Complexities of the pyruvate dehydrogenase complex. Neurology. 51:1998;1247-1249.
24. Shany E., Saada A., Landau D., Shaag A., Hershkovitz E., Elpeleg O.N. Lipoamide dehydrogenase deficiency due to a novel mutation in the interface domain. Biochem. Biophys. Res. Commun. 262:1999;163-166.
25. Brown R.M., Head R.A., Brown G.K. Pyruvate dehydrogenase E3 binding protein deficiency. Hum. Genet. 110:2002;187-191.
26. Lib M.Y., Brown R.M., Brown G.K., Marusich M.F., Capaldi R.A. Detection of pyruvate dehydrogenase E1 α-subunit deficiencies in females by immunohistochemical demonstration of mosaicism in cultured fibroblasts. J. Histochem. Cytochem. 50:2002;877-884.
27. Hanson B.J., Schulenberg B., Patton W.F., Capaldi R.A. A novel subfractionation approach for mitochondrial proteins: a three-dimensional mitochondrial proteome map. Electrophoresis. 22:2001;950-959.
28. Smith S., Cottingham I.R., Ragan C.I. Immunological assays of the NADH dehydrogenase content of bovine heart mitochondria and submitochondrial particles. FEBS Lett. 110:1980;279-282.
29. Batchelor R.H., Zhou M. A resarufin-based fluorescent assay for quantifying NADH. Anal. Biochem. 305:2002;118-119.
30. Roche T.E., Cate R.L. Purification of porcine liver pyruvate dehydrogenase complex and characterization of its catalytic and regulatory properties. Arch. Biochem. Biophys. 183:1977;664-677.
31. Harris R.A., Popov K.M., Shimomura Y., Zhao Y., Jaskiewicz J., Nanaumi N., Suzuki M. Purification, characterization, regulation and molecular cloning of mitochondrial protein kinases. Adv. Enzyme Regul. 32:1992;267-284.
32. Hinman L.M., Blass J.P. An NADH-linked spectrophotometric assay for pyruvate dehydrogenase complex in crude tissue homogenates. J. Biol. Chem. 256:1981;6583-6586.
33. Gohil K., Jones D.A. A sensitive spectrophotometric assay for pyruvate dehydrogenase and oxoglutarate dehydrogenase complexes. Biochem. Rep. 3:1983;1-9.
34. Sheu K.F., Lai J.C., Kim Y.T., Dorante G., Bagg J. Immunochemical characterization of pyruvate dehydrogenase complex in rat brain. J. Neurochem. 44:1985;593-599.
35. Scislowski P.W., Davis E.J. A sensitive spectrophotometric assay of pyruvate dehydrogenase activity. Anal. Biochem. 155:1986;400-404.
36. Haas R.H., Thompson G., Morris B., Conright K., Andrews T. Pyruvate dehydrogenase activity in osmotically shocked rat brain mitochondria: stimulation by oxaloacetate. J. Neurochem. 50:1988;673-680.
37. Wicking C.A., Scholem R.D., Hunt S.M., Brown G.K. Immunochemical analysis of normal and mutant forms of human pyruvate dehydrogenase. Biochem. J. 239:1986;89-96.
38. Wexler I.D., Kerr D.S., Ho L., Lusk M.M., Pepin R.A., Javed A.A., Mole J.E., Jesse B.W., Thekkumkara T.J., Pons G.et al. Heterogeneous expression of protein and mRNA in pyruvate dehydrogenase deficiency. Proc. Natl. Acad. Sci. USA. 85:1988;7336-7340.
39. Schofield P.J., Griffiths L.R., Rogers S.H., Wise G. An improved method for the assay of platelet pyruvate dehydrogenase. Clin. Chim. Acta. 108:1980;219-227.
40. Brooks S.P., Storey K.B. An improvement in the pyruvate dehydrogenase complex assay: a high-yield method for purifying acrylamine acetyltransferase. Anal. Biochem. 212:1993;452-456.
41. Walsh D.A., Cooper R.H., Denton R.M., Bridges B.J., Randle P.J. The elementary reactions of the pig heart pyruvate dehydrogenase complex: a study of the inhibition by phosphorylation. Biochem. J. 157:1976;41-67.
42. Petrick J.S., Jagadish B., Mash E.A., Aposhian H.V. Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem. Res. Toxicol. 14:2001;651-656.
43. Evans O.B. Dichloroacetate tissue concentration and its relationship to hypolactatemia and pyruvate dehydrogenase activation. Biochem. Pharmacol. 31:1982;3124-3126.
44. Evans O.B. Effects of dichloroacetate on brain tissue pyruvate dehydrogenase. J. Neurochem. 41:1983;1052-1056.
45. Gibala M.J., Saltin B. PDH activation by dichloroacetate reduces TCA cycle intermediates at rest but not during exercise in humans. Am. J. Physiol. 277:1999;33-38.